Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda Funds Celiac Asset As Prelude To Potential Acquisition

Jan 06 2017

• By Ian Haydock

businessman and businesswoman are shaking hands and exchanging folder after agreement was reached

Related Content

Celiac Research Partnership Builds Takeda’s GI Interests

Dec 08 2015

Evolving Takeda Signals Intent To Build Around Entyvio, GI Franchise

Jul 11 2016

Related Companies

Takeda Pharmaceutical Co. Ltd.

Altos Therapeutics LLC

Takeda Pharmaceutical Co. Ltd.

AbbVie Inc.

Alvine Pharmaceuticals, Inc.

Alba Therapeutics Corporation

Additional Topics

Research & Development Gastrointestinal

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window